Broad Syndicate of New and Existing Investors  

Causal Network Modeling Provides Powerful Approach to Modeling Complex Biological Systems for Type 2 Diabetes

Automaker to Help Speed One-Step Cellulose-to-Fuels Process to Market

WASHINGTON, May 1 – General Motors Corp. and Mascoma Corp. today announced a strategic relationship to develop cellulosic ethanol focused on Mascoma’s single-step biochemical conversion of non-grain biomass into low-carbon alternative fuels to help address increasing energy demand.

Marathon Oil Corporation Leads Round  

Olympus Corporation to Support the Joint Program through the Provision of Novel Imaging Systems

Collaboration Will Bring Innovative Fluorescent Imaging Agent and System Technologies into Clinical Trials in Ovarian Cancer

"Secret weapon" technology of major consumer goods companies will search through millions of variations of candidates and issues, rapidly evolving the ideal presidential ticket

Lexington, MA (June 24, 2008) – Concert Pharmaceuticals, Inc. announced today that it has been named to the annual FierceBiotech “Fierce 15” list, designating it as one of the top biotechnology companies of 2008. The editors of FierceBiotech evaluated hundreds of privately-held firms based on a variety of factors including company vision, strength of technology, and competitive market position. A complete list of ‘Fierce 15’ companies is available in today’s issue of FierceBiotech and on the FierceBiotech Web site at www.fiercebiotech.com.

Historic investment set for production facility in U.P.’s Chippewa County  

LANSING – Governor Jennifer M. Granholm and Mascoma Corporation CEO Bruce A. Jamerson today announced that the Massachusetts-based company has entered into a series of key strategic relationships to further Mascoma’s efforts to build its first commercial-scale cellulosic ethanol plant in Michigan’s Upper Peninsula.

Surprise findings include Edwards, Clinton and Giuliani losing ground with likely voters due to polarizing appeal; economy is a top issue, Iraq War is not

Company Founded by Pioneers in Emerging Field of Cancer Metabolism